Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024 [Yahoo! Finance]
Milestone Pharmaceuticals Inc. - Common Shares (MIST)
Last milestone pharmaceuticals inc. - common shares earnings: 3/6 07:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
on the development and commercialization of innovative cardiovascular medicines, today announced upcoming data presentations on etripamil at ISPOR 2024 being held in Atlanta, GA on May 5-8, 2024, the 2024 Stanford BioDesign Arrhythmia Technologies Retreat in Boston, MA, on May 15, 2024, and the Annual meeting of the Heart Rhythm Society, Heart Rhythm 2024 , in Boston, MA on May 16-19, 2024. The poster presentations will be available following each embargo at: https://MilestonePharma.com ISPOR Poster Presentation Title: Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Supraventricular Tachycardia (SVT) Episodes Presenter: John Jackimiec, RPh., MBA Date and time: May 6, 3:30 pm EDT Stanford BioDesign Arrhythmia Technologies Retreat Poster Presentation Title: Etripamil Nasal Spray: Data for Acute Rate Control in Atrial Fibrillation with a Rapid Ventricular Rate (AFib-RVR) Presenter: David Bharucha, MD, PhD, FACC Date and ti
Show less
Read more
Impact Snapshot
Event Time:
MIST
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MIST alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MIST alerts
High impacting Milestone Pharmaceuticals Inc. - Common Shares news events
Weekly update
A roundup of the hottest topics
MIST
News
- Milestone Pharmaceuticals (MIST) Upgraded to Buy: Here's What You Should Know [Yahoo! Finance]Yahoo! Finance
- Milestone Pharmaceuticals Inc. (NASDAQ: MIST) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.MarketBeat
- Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate Update [Yahoo! Finance]Yahoo! Finance
- Milestone Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Regulatory and Corporate UpdateGlobeNewswire
- Milestone® Pharmaceuticals Announces Data Presentations on Etripamil at Heart Rhythm 2024, 2024 Stanford BioDesign Arrhythmia Technologies Retreat, and ISPOR 2024GlobeNewswire
MIST
Earnings
- 5/13/24 - Beat
MIST
Sec Filings
- 5/13/24 - Form 8-K
- 5/13/24 - Form 10-Q
- 4/29/24 - Form 10-K/A
- MIST's page on the SEC website